Literature DB >> 25762027

Evaluation of 98 immunocompetent children with cytomegalovirus infection: importance of neurodevelopmental follow-up.

Elif Çelikel1, Hasan Tezer, Saliha Kanik-Yuksek, Belgin Gülhan, Aslinur Ozkaya-Parlakay, Neşe Yaralı.   

Abstract

UNLABELLED: This study aims to analyze and evaluate the clinic and demographic features of immunocompetent children that have been diagnosed with cytomegalovirus (CMV) infection. The data of children diagnosed with CMV infection between January 2005 and December 2010 and their follow-ups for 2 years were retrospectively evaluated. Ninety-eight patients were included, and the median age at admission was 5.6 months (5 days-36 months). 54.1% was male. The diagnosis of CMV infection was performed by measurement of serum anti-CMV specific Ig M and IgG titers and PCR method in blood and/or urine. In 3.06% of the patients, congenital infection was detected, whereas possible congenital infection was observed in 36.7% of the patients. Furthermore, 44 patients (44.8%) were detected to have perinatal infection while postnatal infection was spotted in 15.3% of the patients. The common presenting manifestations were prolonged jaundice, diarrhea, vomiting, abdominal distension, skin eruption, and seizure. And the most common physical examination findings were hepatosplenomegaly, microcephaly, jaundice, and petechia. The mainstream laboratory results were elevated transaminases (50%), anemia (30.6%), leukocytosis (27.5%), and thrombocytopenia (18.3%). There were intracranial calcification in 5.1% and eye findings in 5.1%. On follow-up of patients, complete improvement (59.1%), neuromotor developmental delay (11.2%), epilepsy (10.2%), hearing loss (3.06 %), hemolytic anemia (2.04%), and growth retardation (1.02%) were detected.
CONCLUSION: CMV infection is a significant disease both in congenital and perinatal period. It must be considered that diagnosed patients need to be monitored for a long time with special attention to their neurodevelopmental follow-ups.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25762027     DOI: 10.1007/s00431-015-2513-9

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Congenital and perinatal infections with cytomegalovirus.

Authors:  D E Trincado; W D Rawlinson
Journal:  J Paediatr Child Health       Date:  2001-04       Impact factor: 1.954

Review 2.  Antiviral therapy of congenital cytomegalovirus infection.

Authors:  Mark R Schleiss
Journal:  Semin Pediatr Infect Dis       Date:  2005-01

3.  Hemolytic anemia due to acute cytomegalovirus infection in an immunocompetent adult: a case report and review of the literature.

Authors:  Fabrizio Taglietti; Cecilia M Drapeau; Elisabetta Grilli; Alessandro Capone; Pasquale Noto; Simone Topino; Nicola Petrosillo
Journal:  J Med Case Rep       Date:  2010-10-21

Review 4.  Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.

Authors:  Maher K Gandhi; Rajiv Khanna
Journal:  Lancet Infect Dis       Date:  2004-12       Impact factor: 25.071

5.  Congenital cytomegalovirus infection - a common cause of hearing loss of unknown aetiology.

Authors:  Eva Karltorp; Sten Hellström; Ilona Lewensohn-Fuchs; Eva Carlsson-Hansén; Per-Inge Carlsson; Mona-Lisa Engman
Journal:  Acta Paediatr       Date:  2012-05-16       Impact factor: 2.299

6.  A perinatal cytomegalovirus infection in an immunocompetent patient with chorioretinitis.

Authors:  Saliha Kanik-Yuksek; Belgin Gülhan; Hasan Tezer; Aslinur Ozkaya-Parlakay
Journal:  J Trop Pediatr       Date:  2014-04-25       Impact factor: 1.165

Review 7.  Congenital cytomegalovirus infection: epidemiology and treatment.

Authors:  Richard J Whitley
Journal:  Adv Exp Med Biol       Date:  2004       Impact factor: 2.622

8.  Haemolytic anaemia in previously healthy adult patients with CMV infections: report of two cases and an evaluation of subclinical haemolysis in CMV mononucleosis.

Authors:  C A Horwitz; K Skradski; E Reece; F B Lewis; B Schwartz; R Kelty; H Polesky
Journal:  Scand J Haematol       Date:  1984-07

Review 9.  CMV-induced neonatal thrombocytopenia: a case report and review of the literature.

Authors:  Muhammad Aslam; Jennifer L Anderson; Deborah Guglietti; Dorcas Cardwell
Journal:  Am J Perinatol       Date:  2007-06-27       Impact factor: 1.862

Review 10.  Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.

Authors:  Scott H James; David W Kimberlin; Richard J Whitley
Journal:  Antiviral Res       Date:  2009-05-04       Impact factor: 5.970

View more
  2 in total

1.  Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.

Authors:  Kathleen M Muldoon; Amy Armstrong-Heimsoth; Jodi Thomas
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

2.  Clinical characteristics and treatment courses for cytomegalovirus-associated thrombocytopenia in immunocompetent children after neonatal period.

Authors:  Min Ji Jin; Yunkyum Kim; Eun Mi Choi; Ye Jee Shim; Heung Sik Kim; Jin Kyung Suh; Ji Yoon Kim; Kun Soo Lee; Sun Young Park; Jae Min Lee; Jeong Ok Hah
Journal:  Blood Res       Date:  2018-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.